Brello Health Prepaid Plans vs Monthly GLP-1 Options Compared

Last reviewed: September 16, 2026 Last updated: September 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Brello Health offers no month-to-month option. You pay $399 upfront for three months of compounded semaglutide or $499 for eleven weeks of tirzepatide—both structured as prepaid blocks rather than monthly subscriptions. The effective monthly cost works out to $133 for semaglutide and approximately $197 for tirzepatide when normalized over twelve months (our calculation). Brello's semaglutide block saves $192 annually against PlexusDx's six-month subscription and $432 against the PlexusDx month-to-month rate. Tirzepatide shows a $623 annual advantage over PlexusDx's six-month tier and $1,103 over month-to-month. The trade is liquidity: Brello requires the full block payment at once, while month-to-month plans spread the cost and preserve the option to pause or switch without forfeiting prepaid months.

At-a-glance comparison

All Brello and PlexusDx pricing captured 2026-09-04 and verified current as of 2026-09-16. Brello Health: brellohealth.com; PlexusDx: plexusdx.com.

Normalized twelve-month cost

Brello's prepaid blocks and PlexusDx's monthly subscriptions use different billing cycles, so we normalize to a twelve-month window to compare true annual cost.

Semaglutide over twelve months

Brello Health (3-month prepaid blocks): $399 per block × 4 blocks = $1,596 annually ($133 effective monthly cost, our calculation). You pay $399 every three months.

PlexusDx options:

• Month-to-month: $189 × 12 = $2,268 annually ($189/month)
• 3-month subscription: $169 × 12 = $2,028 annually ($169/month, billed monthly with three-month commitment)
• 6-month subscription: $149 × 12 = $1,788 annually ($149/month, billed monthly with six-month commitment)

Annual difference: Brello saves $192 against the PlexusDx six-month tier and $432 against month-to-month (our calculation).

Tirzepatide over twelve months

Brello Health (11-week prepaid blocks): $499 per block. Twelve months = 52.14 weeks ÷ 11 weeks per block = 4.74 blocks. $499 × 4.74 = $2,365 annually (approximately $197 effective monthly cost, our calculation). You pay $499 every eleven weeks.

PlexusDx options:

• Month-to-month: $289 × 12 = $3,468 annually ($289/month)
• 3-month subscription: $269 × 12 = $3,228 annually ($269/month, billed monthly with three-month commitment)
• 6-month subscription: $249 × 12 = $2,988 annually ($249/month, billed monthly with six-month commitment)

Annual difference: Brello saves $623 against the PlexusDx six-month tier and $1,103 against month-to-month (our calculation).

Decision factors

When upfront commitment delivers the lowest total cost

Brello's prepaid structure produces the lowest twelve-month cost for both semaglutide and tirzepatide among the options in this comparison. The annual savings are material—$192 for semaglutide and $623 for tirzepatide against PlexusDx's six-month tier—but require paying the full block upfront. Semaglutide carries a three-month minimum commitment; you cannot cancel partway through the block and recover unused months. Tirzepatide rebills every eleven weeks but can be canceled anytime, so you avoid future charges without forfeiting prepaid weeks.

This model suits individuals who are confident in their medication choice, have liquidity to cover the block payment, and prioritize minimizing total annual cost. It does not suit those who want to test a compound for a single month, who may need to pause for surgery or illness, or who prefer the flexibility to switch medications mid-cycle without financial penalty.

When month-to-month flexibility justifies higher annual cost

PlexusDx month-to-month billing costs $432 more annually for semaglutide and $1,103 more for tirzepatide than Brello's prepaid blocks (our calculation). That premium buys the ability to pause or cancel after any monthly charge, to switch compounds without forfeiting prepaid months, and to avoid tying up several hundred dollars at once. Clinically, month-to-month makes sense when you are trialing a medication for tolerability, when your insurance or employment situation may change within the quarter, or when cash flow constraints make large upfront payments impractical.

The PlexusDx month-to-month rate also beats Brello on effective cost during any period shorter than three months for semaglutide or eleven weeks for tirzepatide, because Brello requires the full block payment regardless of how long you stay on treatment.

When multi-month subscriptions split the difference

PlexusDx three-month and six-month subscriptions reduce the monthly rate—$169 and $149 respectively for semaglutide, $269 and $249 for tirzepatide—while preserving monthly billing. You commit to the term, but charges spread across each month rather than landing in a single upfront transaction. The six-month tier narrows Brello's annual advantage to $192 for semaglutide and $623 for tirzepatide (our calculation), and the subscription can be renewed or canceled at term end. This structure works when you want a lower rate than month-to-month but need to manage monthly cash flow or prefer not to prepay a quarter or more at once.

Choose Brello Health if…

You have decided on semaglutide or tirzepatide, are confident you will remain on treatment for at least the block duration, and have the liquidity to pay $399 or $499 upfront. Brello delivers the lowest twelve-month cost in this comparison, and the all-inclusive structure means no separate membership or consultation fees. Tirzepatide users gain the ability to cancel future rebills anytime, though the current block is non-refundable. Semaglutide requires completing the three-month minimum before canceling.

Choose a month-to-month plan if…

You are trialing a GLP-1 for the first time, you anticipate needing to pause or switch medications within the first few months, or you prefer to keep monthly expenses predictable without tying up cash in prepaid blocks. The higher annual cost—$2,268 for semaglutide, $3,468 for tirzepatide on PlexusDx month-to-month—buys exit flexibility and the ability to stop or change treatment after each charge clears. This model also avoids the risk of forfeiting unused months if you experience intolerable side effects or your clinical situation changes.

Where PlexusDx multi-month subscriptions fit

PlexusDx three-month and six-month subscriptions reduce the monthly rate below month-to-month—six-month semaglutide at $149/month sits $40 above Brello's effective $133 rate but $40 below the PlexusDx month-to-month rate—while spreading charges across each billing cycle. You commit to the subscription term, but no large upfront block is required, and you pay only for the current month each cycle. The six-month tier costs $192 more annually than Brello's semaglutide blocks and $623 more for tirzepatide (our calculation), a premium that buys monthly liquidity and the ability to cancel at term end rather than forfeiting prepaid weeks mid-block.

PlexusDx holds a 4.3-star rating on Trustpilot, with 79 percent of reviews at five stars and 83 percent at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com).

Methodology and freshness

Brello Health pricing and commitment terms were captured from brellohealth.com on September 4, 2026, and verified current as of September 16, 2026. PlexusDx pricing reflects published rates current as of the same date. Twelve-month cost calculations and effective monthly rates labeled "our calculation" were derived by multiplying or normalizing the published per-block or per-month figures across a twelve-month period. We do not adjust for leap years or partial-week rounding; tirzepatide annual cost assumes 52.14 weeks per year. Brello advertises a $166.33 per-month figure for tirzepatide; we calculate the effective monthly cost over twelve months at approximately $197 based on the eleven-week billing cycle. Readers should confirm all pricing, commitment terms, and cancellation policies at checkout, as published rates and structures may change after our capture date.

Frequently Asked Questions

Does Brello Health offer a month-to-month payment option?

No. Brello requires upfront payment for the full block: $399 for three months of semaglutide or $499 for eleven weeks of tirzepatide. There is no option to pay monthly or to purchase a single month of medication.

Can I cancel Brello after one month and get a refund for unused weeks?

Brello's semaglutide plan has a three-month minimum commitment, and the prepaid block is not pro-rated. Tirzepatide can be canceled anytime to stop future rebills, but the current eleven-week block is non-refundable. You do not recover unused weeks within a paid block.

How does the effective monthly cost of a prepaid block compare to true monthly billing?

Brello's $399 semaglutide block works out to $133 per month over three months, and the $499 tirzepatide block to approximately $197 per month over eleven weeks (our calculation). These are lower than PlexusDx's month-to-month rates but require the full upfront payment. True monthly billing spreads the cost and allows cancellation after each charge.

Which model saves the most money over twelve months?

Brello's prepaid blocks deliver the lowest twelve-month cost in this comparison: $1,596 for semaglutide and $2,365 for tirzepatide (our calculation), compared to $1,788 and $2,988 respectively for PlexusDx six-month subscriptions. The savings are $192 and $623 annually, but require paying each block in full upfront.

Are compounded semaglutide and tirzepatide from Brello and PlexusDx FDA-approved?

No. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. Both Brello and PlexusDx provide compounded GLP-1 medications; neither is FDA-approved or interchangeable with branded drugs like Ozempic or Mounjaro.

Sources

• Brello Health semaglutide pricing and terms, brellohealth.com/home1, accessed September 4, 2026.
• Brello Health tirzepatide pricing and terms, tirzepatidewoo.brellohealth.com, accessed September 4, 2026.
• PlexusDx semaglutide injection pricing, plexusdx.com/products/semaglutide-injection, accessed September 16, 2026.
• PlexusDx tirzepatide injection pricing, plexusdx.com/products/tirzepatide-injection, accessed September 16, 2026.
• PlexusDx Trustpilot reviews, trustpilot.com/review/plexusdx.com, accessed September 9, 2026.

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.